INTRODUCTION
Copyright © February 2015 Creatv MicroTech, Inc., all right reserved CTCs have been shown to be an indicator of malignant disease, used to monitor therapy response and predict outcomes in late stage patients. [1] [2] [3] [4] However, CTCs are not common in all disease stages and are found in low frequencies in a number of cancers, including lung and pancreatic.
CAMLs are immunological cells which have been shown to be present in all stages of cancer, are reactive to cancer treatments, and are found in multiple cancer types. However, these cells have remained largely unstudied.
CellSieve™ microfilters are lithographically fabricated membranes with high porosity, precise pore dimensions, and regular pore distribution [3] [4] . We previously reported that CellSieve™ rapidly and efficiently isolates both CAMLs and CTCs from whole peripheral blood, making it possible to study both cell types in conjunction with and in relation to malignant disease. [3] [4] 
MATERIALS & METHODS

RESULTS
Peripheral blood samples from 100 cancer patients were provided by University of Maryland, Greenebaum Cancer Center, Northwestern University, The Medical College of Wisconsin and Fox Chase Cancer Center. The patient distribution included Stage I (n=21), Stage II (29), Stage III (11), Stage IV (n=39); breast (n=31), pancreatic (n=31), lung (n=9), and prostate (n=29) cancers. We included newly diagnosed/untreated patients (n=42) as well as patients undergoing systemic therapies (n=58). The study included 30 healthy subjects. CellSieve TM microfilters were used to isolate CTCs and CAMLs from 7.5 mL of whole blood. Samples were diluted in a pre-fixation solution and filtered through the microfilters. CTCs and CAMLs collected by this size exclusion technique were fixed, permeabilized, and stained with DAPI, an antibody cocktail against cytokeratins 8, 18 & 19 (FITC), EpCAM (PE), and CD45 (Cy5). CAMLs were defined as large, multinuclear cells with diffuse cytoplasmic cytokeratin. CTCs were defined as filamentous cytokeratin cells that were CD45 negative.
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Highly differentiated monocytic cells, classified as circulating cancer associated macrophage-like cells transit the blood of most cancer patients.
CAMLs may be used as a liquid biopsy for early detection and sequential tracking of cancer.
High prevalence of CAMLs implies that complicated and minimally understood cellular interactions exist in the blood.
CAMLs should be considered when evaluating blood from cancer patients.
Detection, characterization and monitoring of multiple cellular components present in the blood is an essential element in proper characterization of solid tumors. 
